Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals - Sorbonne Université
Journal Articles HIV/AIDS surveillance report (Atlanta, Ga.) Year : 2017

Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals

Abstract

On behalf of the HepACT-VIH study group - Viral coinfections might contribute to the increased immune activation and inflammation that persist in antiretroviral treatment (ART)-treated HIV-1 patients. We investigated whether the hepatitis C virus (HCV) coinfection contributes to such alterations by impairing the plasmacytoid dendritic cell (pDC) IFNa/TLR7 pathway in a highly homogeneous group of ART-treated HIV-1-HCV-coinfected patients.

Domains

Immunology
Fichier principal
Vignette du fichier
Hepatitis_C_virus_drives_increased_type_I.4 (1).pdf (1.98 Mo) Télécharger le fichier
Origin Explicit agreement for this submission
Loading...

Dates and versions

hal-02548458 , version 1 (14-05-2020)

Identifiers

Cite

Morgane Griesbeck, Marc-Antoine Valantin, Karine Lacombe, Assia Samri-Hassimi, Julie Bottero, et al.. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals. HIV/AIDS surveillance report (Atlanta, Ga.), 2017, ⟨10.1097/QAD.0000000000001455⟩. ⟨hal-02548458⟩
159 View
327 Download

Altmetric

Share

More